The Decay

---

Start with the number that should not be possible. The GraniteShares 2x Long NVDA Daily ETF — ticker NVDL,
$3.7 billion in assets — is designed to deliver twice the daily move of Nvidia stock. Over the past twelve
months, Nvidia stock rose roughly 48%. A naive investor would assume that a 2x fund on a stock that rose 48%
made a fortune. And yet over that same period NVDL saw net outflows of about $2.4 billion — investors
pulling money out — and the people who bought in late did not double the 48%; many of them lost money outright.
The fund tracking twice the daily return of a stock that went up by half managed to hand losses to a large
share of the people who held it.

That is not a scandal, exactly. It is not fraud. It is something stranger and more instructive: it is the
product working exactly as designed, doing exactly what the prospectus says it will do, harming the people who
bought it precisely because they did not read — or could not understand — the one sentence that mattered. These
funds reset their leverage daily. They promise 2x the daily return, and the word "daily" is doing more work
than any word in modern finance.

This essay is about leveraged single-stock ETFs — NVDL, TSLL, MSTU, and the four hundred or so funds like them
that now make up nearly a tenth of all U.S.-listed ETFs — and about volatility decay, the mathematical property
that makes them wealth incinerators for anyone who holds them the way retail investors actually hold them. It is
about why the product exists, who profits from it, and why a financial instrument that regulators explicitly say
should not be held for more than a single day is marketed, by ticker and by vibe, as a way to bet big on the
stocks retail loves most.

The arithmetic of the trap

To understand the decay you have to do one small piece of arithmetic, and once you have done it you can never
unsee it. It is the entire game, and it fits in two days.

Take a stock at $100 and a 2x leveraged ETF on it, also priced at $100 for simplicity. On Day 1 the stock rises
10%, to $110. The 2x fund, delivering twice the daily move, rises 20%, to $120. So far so good. On Day 2 the
stock falls back to exactly where it started — a drop from $110 to $100, which is a decline of 9.09%. The 2x
fund falls twice that: 18.18%. And here is the trap. An 18.18% fall from $120 does not bring the fund back to
$100. It brings it to $98.18. The stock is exactly where it began — flat, no gain, no loss. The 2x fund is
down 1.82%. The investor who held the leveraged product for two days, during which the underlying stock did
nothing, lost almost two percent of their money to the mathematics of the daily reset.

Now multiply that across a year of choppy, volatile trading. Every time the stock zig-zags — up one day, down
the next, ending roughly where it was — the leveraged fund bleeds a little more. The decay is not a fee. It is
not a mistake. It is not the issuer skimming. It is a structural, unavoidable consequence of resetting leverage
every single day: to maintain its 2x exposure, the fund is mathematically forced to buy more after the price
rises and sell after it falls — to buy high and sell low, mechanically, every day, forever. In a smoothly
trending market the leverage can work in your favor and the fund can wildly outperform. But in a sideways or
volatile one — which is what single stocks, the most volatile instruments of all, actually deliver — the decay
grinds the holder down even when the stock goes nowhere, and erodes the gains even when the stock goes up. The
more a stock swings, the more a 2x fund on it bleeds. And volatile stocks are exactly the ones these products
are built on, because volatile stocks are exactly the ones retail wants to gamble on.

MSTU, and the ninety percent

If the NVDL story sounds abstract, the MSTU story is the same lesson written in blood. The T-Rex 2x Long MSTR
Daily ETF — a leveraged bet on MicroStrategy, itself a leveraged bet on Bitcoin, making MSTU a leveraged bet on
a leveraged bet — fell more than 90% over twelve months.

Sit with what it takes to lose 90%. MicroStrategy is a famously, extraordinarily volatile stock; that volatility
is the entire reason traders are drawn to a 2x version of it, dreaming of the upside. But volatility is precisely
the input that the decay machine converts into loss. A 2x fund on one of the most violently swinging stocks in
the market is the purest possible expression of volatility drag, and it performed accordingly: it destroyed more
than nine-tenths of the capital of anyone who bought and held. The stock it tracks did not fall 90%. The decay,
amplified by leverage on an asset that whipsawed relentlessly, did the rest. MSTU is not an anomaly or a
malfunction. It is the product's central tendency, revealed under maximum volatility — the warning label
animated.

And note the cruelty of the structure: even traders who were right about MicroStrategy's direction over the
year could have lost catastrophically, because the path mattered more than the destination. In a daily-reset
leveraged product, how a stock gets somewhere determines your return more than where it ends up. You can win
the argument and lose the money. That is not investing. It is a casino game wearing a ticker.

A product designed to be held wrong

Here is the part that turns an interesting mathematical curiosity into something closer to an indictment. Every
regulator who has looked at these products says, in writing, the same thing: they are designed to be held for
no more than a single day. The SEC has warned that daily-reset leveraged and inverse funds can diverge
"quite substantially" from the underlying over any period longer than a day. Compliance lawyers tell advisers
that placing a client in one of these for more than a day requires diligent documentation of why it is in the
client's best interest, because the default assumption is that it is not.

And yet. Look at how they are sold and held. They trade under tickers built to evoke the beloved underlying —
NVDL for the Nvidia faithful, TSLL for the Tesla believers, MSTU for the MicroStrategy-Bitcoin maximalists. They
are marketed, in spirit if not in literal compliance copy, as a way to express conviction — to bet big on the
stock you love. Conviction is a long-term emotion. Nobody feels "conviction" about a position they intend to
close in six hours. The entire emotional pitch of a single-stock leveraged ETF is in direct, irreconcilable
conflict with the single-day holding period that the math requires and the regulators demand. The product is
engineered, in its very branding, to attract exactly the buy-and-hold retail behavior that guarantees the
holder eats the decay.

This is the heart of the forensic case. A product whose safe use is "hold for one day" but whose marketing
summons "hold because you believe" is not a product that occasionally gets misused. It is a product whose
business model depends on misuse — because the issuer collects its fee on assets held, and the assets are held
by people doing the one thing the product punishes.

Follow the fees, and the stalling pile

Now follow the money to the people who are unambiguously winning, because in a product that bleeds its holders,
someone is on the other side of the bleed.

The issuers charge expense ratios on these funds that run around 1% a year or more — many times what a plain
index ETF costs — for the service of providing leverage the holder could approximate more cheaply and far more
safely in other ways. That fee is levied on assets under management regardless of whether the holder makes or
loses money. And the category has ballooned: there are now over 400 single-stock ETFs, nearly 8% of all
U.S.-listed ETFs. The issuers keep minting new ones, slicing the universe of popular stocks into ever more
leveraged and inverse wrappers, because each new fund is a new stream of ~1% fees.

But here is the tell, and it is a beautiful one. Despite the explosion in the number of funds, the total
assets in the category have barely moved — roughly $37.5 billion, up only marginally from about $36
billion nine months earlier. Read that against the proliferation of products and a picture emerges: the industry
is not growing the pie, it is cutting the same pie into more slices. New funds launch; assets do not meaningfully
grow; which means the money sloshing in is roughly matched by the money bleeding out — bled out by the very
decay the products generate. The issuers win on volume and fees regardless. The holders, in aggregate, are
running on a treadmill that the math tilts permanently downhill. Forty thousand-odd retail accounts feeding a
$37.5 billion pile that does not grow, paying 1% a year for the privilege, while the decay quietly does its work
— that is not an investment category. It is a machine for converting retail conviction into issuer revenue.

The house wins both doors

There is a feature of this business so elegant in its design that it deserves to be stated plainly, because it
reveals the issuer's true position. For most popular stocks, the same fund family offers both a leveraged long
ETF and a leveraged inverse — a 2x bull and a 1x or 2x bear on the identical underlying. The bull is for the
believers; the bear is for the skeptics. And both of them decay.

Think about what that means. The volatility-decay math does not care which direction your bet points. A daily-
reset inverse fund, rebalancing every day to maintain its short exposure, suffers the same buy-high-sell-low
erosion as the long version, for the same mathematical reason. So in a choppy, sideways market, both the bulls
holding the long fund and the bears holding the inverse fund can lose money simultaneously, to the same decay,
while the issuer collects roughly 1% from each. The fund family has built a structure in which it sells one
product to the people who think the stock goes up, an opposite product to the people who think it goes down, and
extracts a fee from both while the daily reset quietly degrades both positions. It is the literal casino model:
the house does not care whether you bet red or black, only that you keep playing, and it takes its rake from
every chip on the table. The single-stock-ETF complex has industrialized that arrangement and wrapped it in the
respectable clothing of an exchange-traded fund.

This is why the stalling asset base is so telling. The issuers do not need the category to grow to win. They
need it to churn — money flowing into the bull fund and the bear fund, decaying, flowing back out, replaced by
fresh conviction on both sides. A treadmill that pays a toll at every step does not need to go anywhere to be
profitable for the person who owns the treadmill.

The income cousin, and the same erosion in a different costume

Adjacent to the leveraged funds sits a sister category that runs the same wealth-transfer on a different
mechanism, and it deserves a mention because retail buys it for the same reason and gets hurt the same way. These
are the single-stock option-income ETFs — funds like the YieldMax products on Nvidia and MicroStrategy, with
hundreds of millions to over a billion dollars in assets — that sell covered calls on a volatile stock and pass
the option premium back to holders as an enormous headline "yield," sometimes advertised at fifty or eighty or
a hundred percent annualized.

The yield is real in the narrow sense that the cash is distributed. But where does it come from? Much of it is
not income in any traditional sense; it is, in substantial part, the fund handing investors back their own
capital and the forgone upside of the stock, dressed as a dividend. The covered-call strategy caps the gains
when the stock rises but eats the losses when it falls, and the "distributions" are frequently funded by net
asset value erosion — the share price grinding down over time even as the eye-popping yield is paid. A retail
investor sees "100% yield!" and imagines doubling their money in income; what they often get is a slowly
melting principal returning their own dollars to them with a triumphant label. It is the same trick as the
leveraged funds in a different costume: a headline number engineered to attract retail, attached to a structure
that transfers value from the holder to the strategy over time. The 0DTE income ETFs documented elsewhere in
this series run the identical playbook. The vocabulary changes — "yield" here, "2x" there — but the underlying
move is the same: take the volatility retail finds exciting, package it into a number retail finds irresistible,
and let the mechanics do the quiet work of erosion.

What's genuinely true for the bulls

Be fair, because there is a legitimate use, and pretending these products have none would be as dishonest as the
marketing that obscures their risk.

For a sophisticated trader with a genuinely short-term, directional view, a daily-reset leveraged ETF is a
legitimate and even elegant tool. If you are confident a stock moves sharply in one direction over a day or two,
the leverage delivers, the decay is negligible over so short a window, and you have expressed a precise bet
without options or margin. In a strongly trending market, the daily compounding can even work for you — NVDL
genuinely returned spectacular gains in periods when Nvidia trended cleanly upward, and traders who used it as
designed did very well. The instrument is not a fraud and it is not, used correctly, irrational. The funds do
exactly what they promise: 2x the daily return. Every word of that is honored.

The problem is not the instrument. It is the catastrophic mismatch between what the instrument is and how it is
sold and held. A scalpel is a fine tool; a scalpel marketed to the general public as a kitchen knife, under a
brand that evokes their favorite meal, is a public-health problem. These funds are scalpels sold by ticker to
people who hold them like index funds, and the decay is the cut.

The kicker

The genius of volatility decay as a wealth-transfer mechanism is that nobody has to lie. The prospectus is
accurate. The "daily" is right there in the name. The regulators have issued their warnings. The disclosure is
complete and the math is undisputed. And it does not matter, because the product is engineered — by its ticker,
its leverage, its association with the stocks retail loves — to be held in exactly the way that guarantees the
holder loses to the structure. NVDL handed losses to late buyers of a fund on a stock that rose 48%. MSTU
vaporized 90%. The stocks did not do that. The decay did, faithfully, mechanically, exactly as written, while
the issuers collected their fee on the way down. The most dangerous products in finance are rarely the ones that
lie to you. They are the ones that tell you the truth in a word so small, so technical, so easily skipped, that
the disclosure becomes a kind of camouflage — accurate, complete, and perfectly designed to be overlooked by the
person it is supposed to protect. "Daily" is that word, and four hundred funds and thirty-seven billion dollars
are built on the near-certainty that you will not stop to weigh it.

The stock went up and you still lost money: that sentence should be impossible, and these products make it
routine. Somewhere a retail trader checks a leveraged ticker on a green day for the underlying, sees red on his
own position, and cannot understand why — and the only honest answer is the one printed in the disclosure he
never read, in a single word he never weighed: daily.